CIRM awarded $26 million to advance clinical research across cancer, heart conditions, and rare diseases
On Jun. 28, 2024, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
CPRIT added $52 million to fight against cancer
On May 15, 2024, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it had approved…
Biotechnology | Disease | FDA
Roche announced FDA approval of HPV self-collection solutions in the U.S. , expanding screening to help eliminate cervical cancer
On May 14, 2024, Roche announced the U.S. FDA approval of its human papillomavirus (HPV) self-collection solution, one…
Say “I don’t smoke” You’ll be in good company!
“Say I Don’t Smoke, You’ll be in Good Company” was published by the Irish Cancer Society (ca. 1987).
Break the Habit!
“Break the Habit!,” A quit smoking poster published by the New York State Department of Health, 1989.
Researchers reviewed findings and clinical messages from the Women’s Health Initiative 30 years after launch
On May 1, 2024, researchers at the National Institutes of Health (NIH) announced a review in JAMA that…
Biotechnology | Diagnostics | Disease | Neurology | Non-Profit Research | Ophthalmogy | Therapeutics
CIRM awarded $31 million to fund clinical-stage research for cancers and eye disease
On Apr. 26, 2024, the California Institute for Regenerative Medicine (CIRM) announced it had approved awarding nearly $31…
Biotechnology | Disease | Environmental | EPA | Therapeutics
U.S. Environmental Protection Agency finalized ban on ongoing uses of asbestos to protect people from cancer
On Mar. 18, 2024, the U.S. Environmental Protection Agency (EPA) announced a final rule to prohibit ongoing uses…
California’s Stem Cell Agency awarded $56 million for clinical research, $21.3 million for Shared Labs program
On Feb. 23, 2024, the California Institute for Regenerative Medicine (CIRM) awarded $56 million to fund various clinical…
NIH launched research network to evaluate emerging cancer screening technologies
On Feb. 21, 2024, the National Institutes of Health (NIH) announced it had launched a clinical trials network…
Fred Hutch to lead new federal Cancer Screening Research Network
On Feb. 21, 2024, the Fred Hutchinson Cancer Center announced it was at the helm of a new…
CPRIT approved almost $100 million in grants to advance the fight against cancer in Texas
On Feb. 21, 2024, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it had approved $98,592,155…
Alaska Department of Health confirmed first fatal case of Alaskapox virus
On Feb. 9, 2024, the state of Alaska Department of Health Alaska Department of Health confirmed the first…
Global cancer burden growing, amidst mounting need for services
On Feb. 1, 2024, the World Health Organization (WHO) announced that new estimates on IARCﾒs Global Cancer Observatory…
HPV vaccine study found zero cases of cervical cancer among women vaccinated before age 14
On Jan. 25, 2024, an historic study out of Scotland showed the real-world impact of vaccines against the…
Health effects associated with exposure to secondhand smoke: a Burden of Proof study
On Jan. 9, 2024, the Institute for Health Metrics and Evaluation (HHMI) reported that despite a gradual decline…
Molecular jackhammers’ ‘good vibrations’ eradicate cancer cells
On Dec. 19, 2023, a research team led by Rice University reported they found that the atoms of…
W. Kimryn Rathmell, M.D., Ph.D., began work as 17th director of the National Cancer Institute
On Dec. 18, 2023, W. Kimryn Rathmell, M.D., Ph.D., began work as the 17th director of the National…
Biotechnology | Diagnostics | Disease | Genomics | Neurology | Therapeutics
Alberta researchers revealed full structure of ‘ancient genetic parasite’ implicated in human diseases
On Dec. 14, 2023, the University of Alberta announced that a study published in Nature sheds light on…
Pfizer completed acquisition of Seagen for $43 billion
On Dec. 14, 2023, Pfizer announced it had completed the acquisition of Seagen, a global biotechnology company based…
Using next-gen CRISPR tool, Gladstone scientists created unprecedented molecular map of human immune response
On Dec. 13, 2023, In a study of historic scale, scientists at Gladstone Institutes announced that they had…
University of Missouri research reactor announced commercial shipments of radioisotope for cancer treatment
On Dec. 6, 2023, the University of Missouri Research Reactor (MURR) announced they had completed its first commercial…
Biotechnology | Diagnostics | Disease | Genomics | Neurology | Oncology | Therapeutics
World’s largest genetic project unveiled incredible new data
On Nov. 30, 2023, in a momentous landmark for medical research, UK Biobank announced that it had unveiled…
FDA approved first therapy for rare type of non-cancerous tumorsﾠ
On Nov. 27, 2023, the U.S. Food and Drug Administration approved SpringWorks’ Ogsiveo (nirogacestat) tablets for adult patients…
CPRIT invested $63 million to bring innovative researchers and companies to Texas
On Nov. 15, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it had approved…
Abbott received FDA approval for HPV test to run on Alinity m family of diagnostic assays
On Nov. 2, 2023, Abbott announced that it had received U.S. Food and Drug Administration (FDA) approval for…
Biotechnology | Diagnostics | Medical Device | Neurology | Non-Profit Research | Stem Cell | Therapeutics
California’s Stem Cell Agency invested more than $42.1 million in translational-stage research
On Oct. 27, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $42.1 million to fund various translational…
FDA approved new therapy for rare form of blood cancers called myelodysplastic syndromes
On Oct. 24, 2023, the U.S. Food and Drug Administration approved Servier Pharmaceuticals’ Tibsovo (ivosidenib) for the treatment…
Purdue nameed new pediatric cancer research center for the late Tyler Trent
On Oct. 14, 2023, Purdue University ensured that the memory of the former graduate and devoted Boilermaker football…
Biotechnology | Chemical | Disease | Oncology
California became first U.S. state to ban red dye No. 3
On Oct. 7, 2023, California became the first state to ban four chemicals used in well-known candies and…